Environmental and Experimental Factors Affecting Efficacy Testing of Nonporous Plastic Antimicrobial Surfaces

Test methods for efficacy assessment of antimicrobial coatings are not modelled on a hospital environment, and instead use high humidity (>90%) high temperature (37 °C), and no airflow. Therefore, an inoculum will not dry, resulting in an antimicrobial surface exhibiting prolonged antimicrobial activity, as moisture is critical to activity. Liquids will dry quicker in a hospital ward, resulting in a reduced antimicrobial efficacy compared to

Antimicrobial Coatings applied in healthcare settings – Implications for cleaning procedures.

Program AMiCI WG1&WG4 workshop, Jožef Stefan Institute, LjubljanaTuesday, 20th of March 8:30 Registration 9:00 Welcome by representative St Jožef Stefan Institute Ljubliana 9:15   What have we learnt from living lab studies with AMCs in Healthcare? Francy Crijns, Zuyd University of Applied Sciences (The Netherlands) 9:30   Science meets industry – why are many innovative coating technologies never entering the market? Simone Schulte, Evonik (Germany)

STSM: Fabrication of electrospun antimicrobial nanofibers based on phytochemicals

STSM asignment description: The objective of this STSM is the fabrication of phytochemical based antimicrobial nanofibers via electrospinning which may find application in medical devices for the purpose of infection prevention and control. Through collaboration with TÜBİTAK MRC and Zurich University, it is planned to perform the nanofabrication studies and some of the preliminary morphological characterisations at the Zurich University, and then to done the

STSM: Evaluating the anti-biofilm activity of surfaces composed of ZnO/Ag heterostructures

STSM completed: ZnO/Ag heterostructures are expected to exhibit UVA-induced photocatalytic effect which are due to the presence of ZnO and magnified by the presence of Ag nanoparticles. While these surfaces have been shown to be effective against planktonic bacteria, their action against biofilms is still unknown. As such, the objective of this STSM is to assess the efficacy of ZnO/Ag surfaces against mono- or multi-species

First virtual AMiCI Action Update

Minna and Francy gave virtual AMiCI update through the virtual HILL system on Feb 1st, 2018. It was a very useful and interesting discussion, that morning on HILL. Only a five participants including Minna and Francy, but this made it very personalized and helped to gain a lot of useful information. Here you can see the presentation with the summary of this meeting. Next virtual AMiCI

Antimicrobial Peptides and their Potential to Combat Antimicrobial Resistance Opinion on the Use Of Antimicrobial Coatings In Health-Care Settings

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Maria Olivia Pereira, Assistant Professor University of Minho Department of Biological Engineering Braga, Portugal, Professor in Biomedical Engineering Principal Investigator in the Biofilm Group. This presentation can be also viewed in SlideShare

AMR in Grece: View from the Veterinary Sector

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Dr. Theofilos Papadopoulos, DVM, MSc, MPH, PhD, Aristotle’s University of Thessaloniki, Veterinary Research Institute of Thessaloniki This presentation can be also viewed in SlideShare.

Novel Antimicrobial Strategies to Combat Biomaterial‐Associated Infections Opinion on the use of AMCs in health‐care setting

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Martijn Riool, Postdoc at University of Amsterdam, AMC ‐ CRANIOSAFE (NL STW) Note: this presentation can be also viewed in SlideShare

Emergence and spread of antibiotic resistance

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Tanel Tenson,  Professor in the technology of antimicrobial compounds University of Tartu, Estonia. Note: this presentation can be also viewed in SlideShare

Trends on Health-Care Associated Infections and Infection Control in Estonia and in Europe

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Pille Märtin, Infection control doctor West-Tallinn Central Hospital, Chief specialist Dep. Of Communicable Diseases surveillance and control Health Board of Estonia   Note: this presentation can be also viewed in SlideShare